What is Equinom?
Founded in 2012 and headquartered in Givat Brenner, Israel, Equinom specializes in breeding new non-GMO crop varieties, primarily pea and soy, optimized for the plant-based food industry. Leveraging its proprietary Manna technology platform, which employs advanced algorithms to analyze biochemical and genomic traits, Equinom develops minimally processed ingredients that enhance taste, nutrition, and affordability. This innovative approach allows food companies to create superior sustainable alternatives to meat and dairy products without genetic modification, addressing growing consumer demand for healthier and more environmentally friendly options.
How much funding has Equinom raised?
Equinom has raised a total of $73M across 5 funding rounds:
Series A
$4M
Other Financing Round
$4M
Series B
$10M
Series C
$20M
Other Financing Round
$35M
Series A (2017): $4M with participation from Fortissimo Capital
Other Financing Round (2018): $4M led by Fortissimo Capital
Series B (2020): $10M supported by Roquette, BASF Venture Capital, Fortissimo Capital, and Trendlines Group
Series C (2021): $20M featuring Fortissimo, Trendlines, Maverick, BASF Venture Capital, and Phoenix Group
Other Financing Round (2022): $35M backed by Synthesis Capital and Praesidium
Key Investors in Equinom
BASF Venture Capital
BASF Venture Capital is the corporate venture capital arm of BASF Group, focusing on strategic investments in innovative companies aligned with BASF's business interests, particularly in areas like biotechnology and new materials.
Trendlines Group
Trendlines Group is an investment company dedicated to inventing, discovering, and incubating innovation-based agrifood technologies, with a hands-on approach to business building and technology development.
Synthesis Capital
Synthesis Capital is a venture capital firm that invests in founders transforming the food system through advanced food technology and biotechnology, with a specialization in alternative proteins.
What's next for Equinom?
With its recent major strategic investment and substantial overall capital, Equinom is poised for significant expansion. The company's focus on optimizing core crops through advanced technology positions it to capture a larger share of the burgeoning plant-based food market. Future growth is likely to involve scaling production, further research and development into novel ingredients, and forging deeper partnerships with food manufacturers seeking to innovate their product lines. The enterprise-level backing suggests a strategic push towards market leadership and potentially new product launches that leverage their unique seed-breeding capabilities.
See full Equinom company page
